1. Repository of OAI
Ελληνικά   English  

Browsing by Author Briasoulis, E.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 59 to 78 of 126 < previous   next >
TitleAuthor(s)Issue date???itemlist.???
Leiomyosarcoma as a second metachronous malignant neoplasm following colon adenocarcinoma. A case report and review of the literatureMavrodontidis, A.; Zalavras, C.; Skopelitou, A.; Karavasilis, V.; Briasoulis, E.24-Nov-2015-
Level I evidence in support of perioperative chemotherapy for operable gastric cancer: sufficient for wide clinical use?Briasoulis, E.; Fatouros, M.; Roukos, D. H.24-Nov-2015-
Matrix metalloproteinases in carcinoma of unknown primaryKaravasilis, V.; Malamou-Mitsi, V.; Briasoulis, E.; Tsanou, E.; Kitsou, E.; Kalofonos, H.; Fountzilas, G.; Fotsis, T.; Pavlidis, N.24-Nov-2015-
Mechanisms of resistance to epidermal growth factor receptor tyrosine kinase inhibitors in patients with advanced non-small-cell lung cancer: clinical and molecular considerationsPallis, A.; Briasoulis, E.; Linardou, H.; Papadimitriou, C.; Bafaloukos, D.; Kosmidis, P.; Murray, S.24-Nov-2015-
Megestrol activity in recurrent adult type granulosa cell tumour of the ovaryBriasoulis, E.; Karavasilis, V.; Pavlidis, N.24-Nov-2015-
Metastatic breast carcinoma confined to bone: portrait of a clinical entityBriasoulis, E.; Karavasilis, V.; Kostadima, L.; Ignatiadis, M.; Fountzilas, G.; Pavlidis, N.24-Nov-2015-
Metronomic oral vinorelbine (MOVIN): a dose establishing translational and pharmacokinetic study in patients with metastatic refractory cancerBriasoulis, E.; Tolis, C.; Pappas, P.; Marselos, M.; Nicolaides, C.; Nikiforidis, L.; Nikolaidou, M.; Siarabi, O.; Tzamakou, E.; Pavlidis, N.24-Nov-2015-
Metronomic Oral Vinorelbine in Patients with Recurrent Breast, Prostate or Non-Small Cell Lung Cancer: Optimal Dose-Finding Trial of the Hellenic Cooperative Oncology GroupBriasoulis, E.; Kalofonos, H.; Samantas, E.; Varthalitis, I.; Syrigos, K. N.; Fountzilas, G.; Pappas, P.; Sainis, I.; Puozzo, C.; Pavlidis, N.24-Nov-2015-
Microcystin producing cyanobacterial communities in Amvrakikos Gulf (Mediterranean Sea, NW Greece) and toxin accumulation in mussels (Mytilus galloprovincialis)Vareli, K.; Zarali, E.; Zacharioudakis, G. S. A.; Vagenas, G.; Varelis, V.; Pilidis, G.; Briasoulis, E.; Sainis, I.24-Nov-2015-
Microvessel density and immunohistochemical expression of angiogenic proteins VEGF, VEGFR1 and VEGFR2 in gastric adenocarcinomaLampri, E.; Goussia, A.; Sintou-Mantela, E.; Balasi, E.; Charchanti, A.; Kamina, S.; Capizzelo, A.; Tsekeris, P.; Briasoulis, E.; Malamou-Mitsi, V.; Agnantis, N. J.; Bai, M.24-Nov-2015-
Molecular characterization of cyanobacterial diversity and yearly fluctuations of Microcystin loads in a suburban Mediterranean Lake (Lake Pamvotis, Greece)Vareli, K.; Pilidis, G.; Mavrogiorgou, M. C.; Briasoulis, E.; Sainis, I.24-Nov-2015-
Molecular confirmation of Planktothrix rubescens as the cause of intense, microcystin-Synthesizing cyanobacterial bloom in Lake Ziros, GreeceVareli, K.; Briasoulis, E.; Pilidis, G.; Sainis, I.24-Nov-2015-
Molecular genetic tools shape a roadmap towards a more accurate prognostic prediction and personalized management of cancerRoukos, D. H.; Murray, S.; Briasoulis, E.24-Nov-2015-
Multicenter phase-II trial of irinotecan plus oxaliplatin [IROX regimen] in patients with poor-prognosis cancer of unknown primary: a hellenic cooperative oncology group studyBriasoulis, E.; Fountzilas, G.; Bamias, A.; Dimopoulos, M. A.; Xiros, N.; Aravantinos, G.; Samantas, E.; Kalofonos, H.; Makatsoris, T.; Mylonakis, N.; Papakostas, P.; Skarlos, D.; Varthalitis, I.; Pavlidis, N.24-Nov-2015-
Myelotoxicity as a prognostic factor in patients with advanced breast cancer treated with chemotherapy: a pooled analysis of two randomised trials conducted by the Hellenic Cooperative Oncology GroupKoutras, A. K.; Fountzilas, G.; Dafni, U.; Dimopoulos, M. A.; Pectasides, D.; Klouvas, G.; Papakostas, P.; Kosmidis, P.; Samantas, E.; Gogas, H.; Briasoulis, E.; Vourli, G.; Petsas, T.; Xiros, N.; Kalofonos, H. P.24-Nov-2015-
Near-absolute expression of the bcl-2 protein identifies a subgroup of stage II breast cancer patients with a most favorable outcome. Results of a clinicopathological studyBriasoulis, E.; Agnantis, N. J.; Zagorianakou, P.; Kamina, S.; Gorezi, M.; Pavlidis, N.; Bai, M.24-Nov-2015-
The neutrophil, not the tumor: serum CA 15-3 elevation as a result of granulocyte--colony-stimulating factor-induced neutrophil MU1C overexpression and neutrophilia in patients with breast carcinoma receiving adjuvant chemotherapyPentheroudakis, G.; Malamou-Mitsi, V.; Briasoulis, E.; Damala, K.; Vassou, A.; Vartholomatos, G.; Kolaitis, N.; Pavlidis, N.24-Nov-2015-
Noncardiogenic pulmonary edema: an unusual and serious complication of anticancer therapyBriasoulis, E.; Pavlidis, N.24-Nov-2015-
NT5E (CD73) is epigenetically regulated in malignant melanoma and associated with metastatic site specificityWang, H.; Lee, S.; Nigro, C. L.; Lattanzio, L.; Merlano, M.; Monteverde, M.; Matin, R.; Purdie, K.; Mladkova, N.; Bergamaschi, D.; Harwood, C.; Syed, N.; Szlosarek, P.; Briasoulis, E.; McHugh, A.; Thompson, A.; Evans, A.; Leigh, I.; Fleming, C.; Inman, G. J.; Hatzimichael, E.; Proby, C.; Crook, T.24-Nov-2015-
Oxaliplatin (Eloxatin) plus irinotecan combination chemotherapy found effective in refractory metastatic insular thyroid carcinomaBriasoulis, E.; Rontogianni, D.; Karavasilis, V.; Pavlidis, N.24-Nov-2015-
Showing results 59 to 78 of 126 < previous   next >